Search this website
Home
Tumour Sites
Sub Groups or Cross Cutting Groups
Terms of Reference
Tumour Site Specific Information
Medicines & Prescribing
Governance & SOPs
Network Chemotherapy Prescription Proformas/Protocols (NHS Staff use)
Additional Prescribing Documents
SACT Pathways
Guidelines for the Management of SACT Induced Adverse Reactions
ICI Immunotherapy
Nursing
Oncological Treatment Guidelines
E Prescribing Documents
Patients, Carers and Community
NHS Hospital Cancer Services
Hospice Information
Information and Resources
About us
Kent & Medway Cancer Collaborative (KMCC) team
Supportive Care
SUPP-001 Zoledronic Acid v2
SUPP-002 Calcium & Magnesium as Adjunctive Treatment for Oxaliplatin Induced Neuropathy v4
SUPP-003 Denosumab (Xgeva®) every 4 or 6 weeks
SUPP-005 Zoledronic Acid v1
SUPP-006 Denosumab every 12 weeks v1